Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention
Jennifer Y. Xie(Arkansas State University), Frank Porreca(University of Arizona), Hugh Rosen(La Jolla Institute for Immunology), Pablo Hernández(University of Arizona), John M. Streicher(University of Arizona), Nathan Eyde(University of Arizona), Milena De Felice(University of Sheffield), Michael H. Ossipov(University of Arizona), David W. Dodick(Mayo Clinic Hospital), Tamara King(University of New England), Justin LaVigne(University of Arizona), Ed Roberts(Charing Cross Hospital), Edita Navratilova(University of Arizona), Naomi Goshima(University of Arizona), Bethany Remeniuk(University of Arizona), Caroline Machado Kopruszinski(Universidade Federal do Paraná), Xu Yue(University of Arizona)
Cited by 86
Related Papers
Central modulation of pain
|Journal of Clinical Investigation|2010|1.1k
Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate
|Journal of Biological Chemistry|2004|621
Diverse Actions of Ovarian Steroids in the Serotonin Neural System
|Frontiers in Neuroendocrinology|2002|485